Dasanat Dasatinib 20mg Tablets Natco Pharma

Get a Price/Quote

MOQ : 100 Pieces

Dasanat Dasatinib 20mg Tablets Natco Pharma Specification

Salt Composition
Dasatinib 20 mg

Dosage Form
Tablet

Indication
Treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

Feature
Prescription only, targeted tyrosine kinase inhibitor

Application
Oncology, targeted cancer therapy

Physical Color/Texture
White to off-white tablets

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Prescription Category
Rx Only

Brand Name
Dasanat

Therapeutic Class
Anticancer, Antineoplastic

Packaging Size
60 tablets per bottle

Marketed By
Natco Pharma

Route of Administration
Oral

Strength
20 mg

Dasanat Dasatinib 20mg Tablets Natco Pharma Trade Information

Minimum Order Quantity
100 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Pieces Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Dasanat Dasatinib 20mg Tablets Natco Pharma About

Experience brilliant results with Dasanat Dasatinib 20mg Tablets by Natco Pharma, a highlighted therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). For a limited time, redeem rapid, flawless treatment support with this targeted tyrosine kinase inhibitor, designed to help patients achieve soaring health improvements. Packaged conveniently with 60 tablets per bottle and crafted for oral administration, Dasanat ensures ease of use. Strict RX-only access and 24-month shelf life guarantee a secure, long-lasting solution. Don't miss this opportunity for exceptional oncology care.

Unmatched Efficacy & Leading Features

Dasanat Dasatinib 20mg Tablets Natco Pharma are celebrated for their primary competitive advantage: precise, targeted action against CML and Ph+ ALL. The special features include flawless oral dosing, rapid onset of action, and a robust 24-month shelf life. These attributes make Dasanat a standout option in the application area of oncology, especially for patients seeking brilliant, sustained responses through innovative cancer therapy.

Export Highlights, Certifications & Outlay Considerations

Dasanat Dasatinib 20mg Tablets Natco Pharma ships via leading FOB ports across India, ensuring swift exchange to international destinations. Outlay and charge terms are competitive for global buyers. The main export markets include Asia, Africa, and Europe, reflecting wide acceptance. Certified by stringent regulatory authorities, Dasanat upholds international standards for safety and efficacy, reinforcing trust among manufacturers, suppliers, and traders.

FAQ's of Dasanat Dasatinib 20mg Tablets Natco Pharma:

Q: How should Dasanat Dasatinib 20mg Tablets be stored?

A: Dasanat Dasatinib 20mg Tablets should be stored below 30C and protected from moisture. Proper storage ensures the medication retains its effectiveness throughout its 24-month shelf life.

Q: What are the main therapeutic uses of Dasanat Dasatinib 20mg Tablets?

A: Dasanat Dasatinib 20mg Tablets are indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), offering a targeted approach in oncology.

Q: When should a patient consider Dasanat Dasatinib therapy?

A: Dasanat should be considered under the guidance of a healthcare professional when diagnosed with CML or Ph+ ALL, as part of a comprehensive cancer treatment plan.

Q: Where is Dasanat Dasatinib manufactured and marketed?

A: Dasanat Dasatinib is manufactured and marketed in India by Natco Pharma, a reputable and internationally recognized pharmaceutical company.

Q: What is the process for redeeming Dasanat Dasatinib 20mg Tablets internationally?

A: International buyers can redeem Dasanat by engaging with certified suppliers, traders, or exporters who adhere to regulatory and charge protocols, ensuring safe exchange and delivery.

Q: How can Dasanat benefit patients with leukemia?

A: Dasanat works as a targeted tyrosine kinase inhibitor to effectively block cancer cell growth in CML and Ph+ ALL, helping patients achieve improved health outcomes with fewer off-target effects.

Tell us about your requirement